Correction to: On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis

被引：0
作者：
Vivian P. Bykerk
Gerd R. Burmester
Bernard G. Combe
Daniel E. Furst
Tom W. J. Huizinga
Harris A. Ahmad
Paul Emery
机构：
[1] Weill Cornell Medical College,Department of Rheumatology, Hospital for Special Surgery
[2] Charité–University Medicine Berlin,Department of Rheumatology and Clinical Immunology
[3] Service d’Immuno-Rheumatologie,Department of Rheumatology
[4] University of California Los Angeles,Department of Medicine
[5] Leiden University Medical Center,Department of Rheumatology
[6] Bristol-Myers Squibb,Headquarters Medical Immunology
[7] University of Leeds,Leeds Institute of Rheumatic and Musculoskeletal Medicine
[8] Leeds Teaching Hospitals NHS Trust,NIHR Leeds Musculoskeletal Biomedical Research Unit
来源：
Rheumatology International | 2019年 / 39卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The article “On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis”, written by Vivian P.Bykerk, was originally published Online First without open access.
引用
收藏
页码：945 / 945
相关论文
共 50 条
  • [21] Two Composite Cytokine Scores Predict Flare and Drug-free Remission in Patients with Rheumatoid Arthritis
    Sim, Jasmine
    Ramamoorthi, Nandhini
    Rayner, Fiona
    Degnan, Abbie
    Wilson, Imogen
    Diboll, Julie
    Guttman, Anna
    Melville, Andrew
    Rathore, Nisha
    Siebert, Stefan
    McInnes, Iain
    Goodyear, Carl
    Hilkens, Catharien
    Filer, Andrew
    Raza, Karim
    Buckley, Christopher
    Pratt, Arthur
    Wason, James
    Anderson, Amy
    Townsend, Michael
    Baker, Kenneth
    Isaacs, John
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2740 - 2742
  • [22] Determinants of reaching drug-free remission in patients with early rheumatoid or undifferentiated arthritis after one year of remission-steered treatment
    Wevers-de Boer, Kirsten V. C.
    Heimans, Lotte
    Visser, Karen
    Schouffoer, Anne A.
    Molenaar, Esmeralda T. H.
    van Groenendael, Johannes H. L. M.
    Peeters, Andre J.
    Speyer, Irene
    Collee, Gerard
    Huizinga, Tom W. J.
    Allaart, Cornelia F.
    RHEUMATOLOGY, 2015, 54 (08) : 1380 - 1384
  • [23] Inducibility or predestination? Queries and concepts around drug-free remission in rheumatoid arthritis
    D'Onofrio, Bernardo
    van der Helm-van Mil, Annette
    Huizinga, Tom W. J.
    van Mulligen, Elise
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (02) : 217 - 225
  • [24] Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: insights from systems biology
    Xavier M Teitsma
    Wei Yang
    Johannes W G Jacobs
    Attila Pethö-Schramm
    Michelle E A Borm
    Amy C Harms
    Thomas Hankemeier
    Jacob M van Laar
    Johannes W J Bijlsma
    Floris P J G Lafeber
    Arthritis Research & Therapy, 20
  • [25] Clinical characteristics associated with drug-free sustained remission in patients with rheumatoid arthritis: Data from Korean Intensive Management of Early Rheumatoid Arthritis (KIMERA)
    Jung, Seung Min
    Pyo, Jung Yoon
    Lee, Sang-Won
    Song, Jason Jungsik
    Lee, Soo-Kon
    Park, Yong-Beom
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2020, 50 (06) : 1414 - 1420
  • [26] Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: insights from systems biology
    Teitsma, Xavier M.
    Yang, Wei
    Jacobs, Johannes W. G.
    Petho-Schramm, Attila
    Borm, Michelle E. A.
    Harms, Amy C.
    Hankemeier, Thomas
    van Laar, Jacob M.
    Bijlsma, Johannes W. J.
    Lafeber, Floris P. J. G.
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
  • [27] Sustained biologic-free and drug-free remission in rheumatoid arthritis, where are we now?
    Nagy, Gyoergy
    van Vollenhoven, Ronald F.
    ARTHRITIS RESEARCH & THERAPY, 2015, 17
  • [28] Sustained biologic-free and drug-free remission in rheumatoid arthritis, where are we now?
    György Nagy
    Ronald F van Vollenhoven
    Arthritis Research & Therapy, 17
  • [29] Defining the Optimal Strategies for Achieving Drug-Free Remission in Rheumatoid Arthritis: A Narrative Review
    Gul, Hanna
    Harnden, Kate
    Saleem, Benazir
    HEALTHCARE, 2021, 9 (12)
  • [30] Tapering conventional synthetic DMARDs towards sustained drug-free remission in rheumatoid arthritis
    van Mulligen, Elise
    LANCET RHEUMATOLOGY, 2024, 6 (05) : e254 - e255
12345